Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity
暂无分享,去创建一个
S. Batra | Sakthivel Muniyan | M. Macha | Koelina Ganguly | S. Chaudhary | Zafar Sayed | R. Pothuraju | Dwight T Jones
[1] Xin Wang,et al. Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways , 2019, Cancer Cell International.
[2] K. D. de Visser,et al. Cancer‐Cell‐Intrinsic Mechanisms Shaping the Tumor Immune Landscape , 2018, Immunity.
[3] C. Bradford,et al. Understanding Interactions of Smoking on Prognosis of HPV-Associated Oropharyngeal Cancers , 2018, Advances in Therapy.
[4] E. Flemington,et al. Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate , 2017, Scientific Reports.
[5] S. H. van der Burg,et al. Intratumoral HPV16-Specific T Cells Constitute a Type I–Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer , 2017, Clinical Cancer Research.
[6] J. Schiller,et al. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases , 2017, Cancer.
[7] Michael D. Buck,et al. Metabolic Instruction of Immunity , 2017, Cell.
[8] C. Chung,et al. E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] SangKon Oh,et al. Dendritic cell targeting vaccine for HPV-associated cancer , 2017, Cancer cell & microenvironment.
[10] Ashley V. Menk,et al. Efficacy of PD-1 Blockade Is Potentiated by Metformin-Induced Reduction of Tumor Hypoxia , 2016, Cancer Immunology Research.
[11] T. Fenton,et al. CD8 þ T cell response to human papillomavirus 16 E7 is able to predict survival outcome in oropharyngeal cancer , 2016 .
[12] A. Hakimi,et al. The head and neck cancer immune landscape and its immunotherapeutic implications. , 2016, JCI insight.
[13] M. Disis,et al. Clinical significance of tumor-infiltrating lymphocytes in breast cancer , 2016, Journal of Immunotherapy for Cancer.
[14] G. Wolf,et al. Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer. , 2016, Oral oncology.
[15] M. Desai,et al. Racial and Ethnic Variations in Lung Cancer Incidence and Mortality: Results From the Women's Health Initiative. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Xin-hua Liang,et al. The etiologic spectrum of head and neck squamous cell carcinoma in young patients , 2016, Oncotarget.
[17] Jong Y. Park,et al. Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis , 2016, Head & neck.
[18] D. de Ruysscher,et al. Tumor infiltrating lymphocytes in lung cancer: a new prognostic parameter. , 2016, Journal of thoracic disease.
[19] N. Lee,et al. Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response. , 2016, Clinical oncology (Royal College of Radiologists (Great Britain)).
[20] Jeremy MG Taylor,et al. Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma , 2016, Head & neck.
[21] S. Faraj,et al. Prevalence of human papillomavirus types and variants and p16INK4a expression in head and neck squamous cells carcinomas in São Paulo, Brazil , 2016, Infectious Agents and Cancer.
[22] M. von Knebel Doeberitz,et al. CD56‐positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma , 2016, International journal of cancer.
[23] C. Jackson,et al. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. , 2016, Journal of gastrointestinal oncology.
[24] Y. Ko,et al. Somatic Mutations and Genetic Variants of NOTCH1 in Head and Neck Squamous Cell Carcinoma Occurrence and Development , 2016, Scientific Reports.
[25] B. Egleston,et al. The Impact of Health Insurance Status on the Presentation, Local Management, and Outcomes of Patients With Head and Neck Cancer in the United States , 2016 .
[26] C. Bradford,et al. Socioeconomic and Other Demographic Disparities Predicting Survival among Head and Neck Cancer Patients , 2016, PloS one.
[27] Rob J. Kulathinal,et al. Ancestral-derived effects on the mutational landscape of laryngeal cancer. , 2016, Genomics.
[28] C. Thompson,et al. The Emerging Hallmarks of Cancer Metabolism. , 2016, Cell metabolism.
[29] D. van Baarle,et al. Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma , 2016, Future science OA.
[30] Simion I. Chiosea,et al. Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. , 2016, The Journal of clinical investigation.
[31] C. Van Waes,et al. Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches , 2015, Cancers.
[32] E. Vokes,et al. HPV-Associated Head and Neck Cancer. , 2015, Journal of the National Cancer Institute.
[33] A. Kataki,et al. Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of India , 2015, PloS one.
[34] R. Schreiber,et al. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression , 2015, Cell.
[35] P. Stern,et al. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma , 2015, British Journal of Cancer.
[36] S. Ramamoorthy,et al. Tumor‐infiltrating CD8+ T lymphocytes associated with clinical outcome in anal squamous cell carcinoma , 2015, Journal of surgical oncology.
[37] J. Beijnen,et al. HPV-negative squamous cell carcinoma of the anal canal is unresponsive to standard treatment and frequently carries disruptive mutations in TP53 , 2015, British Journal of Cancer.
[38] Z. Naraghi,et al. Tumor-Infiltrating CD8+ Lymphocytes Effect on Clinical Outcome of Muco-Cutaneous Melanoma , 2015, Indian journal of dermatology.
[39] Antonio Rosato,et al. Mutant p53 reprograms TNF signaling in cancer cells through interaction with the tumor suppressor DAB2IP. , 2014, Molecular cell.
[40] C. Harris,et al. p53 mutations and inflammation-associated cancer are linked through TNF signaling. , 2014, Molecular cell.
[41] J. Califano,et al. Sequencing the head and neck cancer genome: implications for therapy , 2014, Annals of the New York Academy of Sciences.
[42] R. Konwar,et al. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast , 2014, The Indian journal of medical research.
[43] Jennifer J. Hu,et al. Ethnicity and Clinical Outcomes in Head and Neck Cancer: an Analysis of the SEER Database , 2014, Journal of Racial and Ethnic Health Disparities.
[44] Claus Hellerbrand,et al. Immunologic and metabolic characteristics of HPV-negative and HPV-positive head and neck squamous cell carcinomas are strikingly different , 2014, Virchows Archiv.
[45] M. Rusan,et al. The interplay between HPV and host immunity in head and neck squamous cell carcinoma , 2014, International journal of cancer.
[46] A. Psyrri,et al. HPV and head and neck cancers: state-of-the-science. , 2014, Oral oncology.
[47] Nadarajah Vigneswaran,et al. Epidemiologic trends in head and neck cancer and aids in diagnosis. , 2014, Oral and maxillofacial surgery clinics of North America.
[48] Adam Luginbuhl,et al. Tumor microenvironment in head and neck squamous cell carcinoma. , 2014, Seminars in oncology.
[49] S. Franceschi,et al. Racial disparities in Human Papillomavirus (HPV) associated head and neck cancer. , 2014, American journal of otolaryngology.
[50] E. King,et al. Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer , 2013, British Journal of Cancer.
[51] E. Rosenthal,et al. Analysis and Review of Outcomes for Cutaneous Squamous Cell Carcinoma Involving the Parotid , 2013 .
[52] A. Olshan,et al. Health‐related quality of life differences between African Americans and non‐Hispanic whites with head and neck cancer , 2013, Head & neck.
[53] G. Jefferson,et al. Socioeconomic Disparities in Mississippi Head and Neck Cancer Patients , 2013 .
[54] T. Nyberg,et al. CD8+ and CD4+ tumour infiltrating lymphocytes in relation to human papillomavirus status and clinical outcome in tonsillar and base of tongue squamous cell carcinoma. , 2013, European journal of cancer.
[55] Q. Wei,et al. Low risk of second primary malignancies among never smokers with human papillomavirus–associated index oropharyngeal cancers , 2013, Head & neck.
[56] Amy Y. Chen,et al. Treatment patterns and survival among low-income medicaid patients with head and neck cancer. , 2013, JAMA otolaryngology-- head & neck surgery.
[57] B. Leiby,et al. Cancer metabolism, stemness and tumor recurrence , 2013, Cell cycle.
[58] T. Whiteside. Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis? , 2013, Front. Oncol..
[59] N. Kokot,et al. Immune cell infiltration patterns and survival in head and neck squamous cell carcinoma. , 2013, Head & neck oncology.
[60] Wei Xu,et al. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[61] L. Alemany,et al. Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis. , 2012, Vaccine.
[62] S. Franceschi,et al. Characteristics and survival of head and neck cancer by HPV status: a cancer registry‐based study , 2012, International journal of cancer.
[63] S. Pai,et al. Biology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers. , 2012, Otolaryngologic clinics of North America.
[64] S. H. van der Burg,et al. Systemic and local human papillomavirus 16‐specific T‐cell immunity in patients with head and neck cancer , 2012, International journal of cancer.
[65] H. Johansson,et al. Tumor Infiltrating CD8+ and Foxp3+ Lymphocytes Correlate to Clinical Outcome and Human Papillomavirus (HPV) Status in Tonsillar Cancer , 2012, PloS one.
[66] M. Plummer,et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. , 2012, The Lancet. Oncology.
[67] S. Boccia,et al. A review of genetic epidemiology of head and neck cancer related to polymorphisms in metabolic genes, cell cycle control and alcohol metabolism , 2012, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.
[68] Jeremy MG Taylor,et al. Infiltrating lymphocytes and human papillomavirus‐16–associated oropharyngeal cancer , 2012, The Laryngoscope.
[69] Esther Kim,et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] R. Gibbs,et al. Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.
[71] Scott M Langevin,et al. Determinants of head and neck cancer survival by race , 2011, Head & neck.
[72] A. McKenna,et al. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.
[73] A. Jemal,et al. Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.
[74] J. Gordon,et al. Human nutrition, the gut microbiome and the immune system , 2011, Nature.
[75] J. Bussink,et al. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4 , 2011, BMC Cancer.
[76] S. Ishman,et al. Racial/ethnic and socioeconomic disparities in the diagnosis and treatment of sleep-disordered breathing in children. , 2011, International journal of pediatric otorhinolaryngology.
[77] Everett E. Vokes,et al. Head and neck cancer in 2010: Maximizing survival and minimizing toxicity , 2011, Nature Reviews Clinical Oncology.
[78] T. Schrank,et al. Case‐matching analysis of head and neck squamous cell carcinoma in racial and ethnic minorities in the United States—Possible role for human papillomavirus in survival disparities , 2011, Head & neck.
[79] M. Stanley. HPV - immune response to infection and vaccination , 2010, Infectious Agents and Cancer.
[80] S. Syrjänen. The role of human papillomavirus infection in head and neck cancers. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[81] J. Lee,et al. Human papillomavirus‐active head and neck cancer and ethnic health disparities , 2010, The Laryngoscope.
[82] K. Ang,et al. Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.
[83] S. Lippman,et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) , 2010, Head & neck oncology.
[84] H. Ohtani,et al. Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[85] J. Palefsky,et al. Human papillomavirus-related disease in men: not just a women's issue. , 2010, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.
[86] N. Benowitz,et al. New CYP2A6 gene deletion and conversion variants in a population of Black African descent. , 2010, Pharmacogenomics.
[87] Anjali K. Gupta,et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. , 2009, Archives of otolaryngology--head & neck surgery.
[88] M. Suntharalingam,et al. Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients , 2009, Cancer Prevention Research.
[89] N. Benowitz,et al. Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African‐American Light Smokers , 2009, Clinical pharmacology and therapeutics.
[90] Albert C. Koong,et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. , 2009, International journal of radiation oncology, biology, physics.
[91] W. Quint,et al. Persistence of an Incident Human Papillomavirus Infection and Timing of Cervical Lesions in Previously Unexposed Young Women , 2009, Cancer Epidemiology Biomarkers & Prevention.
[92] P. Succop,et al. Racial/ethnic differences in patterns of sexual behavior and STI risk among sexually experienced adolescent girls. , 2009, Journal of pediatric and adolescent gynecology.
[93] D. Hayes,et al. Molecular biology of head and neck cancer: risks and pathways. , 2008, Hematology/oncology clinics of North America.
[94] L. Koniaris,et al. African American and poor patients have a dramatically worse prognosis for head and neck cancer , 2008, Cancer.
[95] G. Wolf,et al. Interleukin‐6 predicts recurrence and survival among head and neck cancer patients , 2008, Cancer.
[96] T. Byers,et al. The impact of socioeconomic status on survival after cancer in the United States , 2008, Cancer.
[97] R. Tyndale,et al. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent , 2008, Human mutation.
[98] W. Westra,et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. , 2008, Journal of the National Cancer Institute.
[99] Jennifer J. Hu,et al. Unequal burden of head and neck cancer in the United States , 2008, Head & neck.
[100] Amy Y. Chen,et al. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. , 2008, The Lancet. Oncology.
[101] A. Cmelak,et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.
[102] A. Chaturvedi,et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[103] T. Whiteside,et al. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer , 2007, International journal of cancer.
[104] Amy Y. Chen,et al. Health insurance and stage at diagnosis of laryngeal cancer: does insurance type predict stage at diagnosis? , 2007, Archives of otolaryngology--head & neck surgery.
[105] N. Bhardwaj. Harnessing the immune system to treat cancer. , 2007, The Journal of clinical investigation.
[106] J. Sterne,et al. Human papillomavirus and head and neck cancer: a systematic review and meta‐analysis , 2006, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.
[107] R. Podolsky,et al. Racial Disparities in Patients With Head and Neck Squamous Cell Carcinoma , 2006, The Laryngoscope.
[108] J. Doorbar,et al. Molecular biology of human papillomavirus infection and cervical cancer. , 2006, Clinical science.
[109] A. Marrogi,et al. Unlimited Access to Care: Effect on Racial Disparity and Prognostic Factors in Lung Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.
[110] R. Ferris,et al. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. , 2005, Cancer Research.
[111] Zhao Chen,et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. , 2005, Journal of the National Cancer Institute.
[112] S. Syrjänen. Human papillomavirus (HPV) in head and neck cancer. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[113] T. Whiteside,et al. Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer , 2005, British Journal of Cancer.
[114] S. Franceschi,et al. Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review , 2005, Cancer Epidemiology Biomarkers & Prevention.
[115] Margaret Brandwein-Gensler,et al. Oral Squamous Cell Carcinoma: Histologic Risk Assessment, but Not Margin Status, Is Strongly Predictive of Local Disease-free and Overall Survival , 2005, The American journal of surgical pathology.
[116] W. Mendenhall,et al. Impact of race on outcome after definitive radiotherapy for squamous cell carcinoma of the head and neck , 2003, Cancer.
[117] Kyle Steenland,et al. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. , 2002, American journal of epidemiology.
[118] F. Bosch,et al. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.
[119] C. Miller,et al. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. , 2001, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[120] V. J. Winter,et al. Structural basis for altered activity of M‐ and H‐isozyme forms of human lactate dehydrogenase , 2001 .
[121] M. Lehtinen,et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. , 2001, The New England journal of medicine.
[122] D. Sidransky,et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.
[123] L. Banks,et al. Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[124] G. Funk,et al. The National Cancer Data Base report on cancer of the head and neck. , 1998, Archives of otolaryngology--head & neck surgery.
[125] E. Perez-stable,et al. Nicotine metabolism and intake in black and white smokers. , 1998, JAMA.
[126] J. Nevins,et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[127] Natale Cascinelli,et al. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma , 1996, Cancer.
[128] E. H. Johnson,et al. What is the significance of black-white differences in risky sexual behavior? , 1994, Journal of the National Medical Association.
[129] K. Münger,et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. , 1989, Science.
[130] S. Syrjänen,et al. Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. , 1983, International journal of oral surgery.
[131] W. Richtsmeier. Human interferon production in tonsil and adenoid tissue cultures. , 1983, American journal of otolaryngology.
[132] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.
[133] A. Bosserhoff,et al. Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma. , 2018, The American journal of pathology.
[134] S. Franceschi,et al. HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. , 2017, Oncotarget.
[135] G. Nabi,et al. Socio-economic deprivation and outcomes following radical nephroureterectomy for clinically localized upper tract transitional cell carcinoma , 2014, World Journal of Urology.
[136] Patrice Ravel,et al. PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. , 2013, Cancer research.
[137] A. Garden,et al. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center , 2013, Cancer.
[138] J. Dowd,et al. Family poverty is associated with cytomegalovirus antibody titers in U.S. children. , 2012, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[139] N. Benowitz,et al. Nicotine chemistry, metabolism, kinetics and biomarkers. , 2009, Handbook of experimental pharmacology.
[140] V. Shavers,et al. Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35 , 2003, Cancer.
[141] J. Gluckman,et al. African‐American and white head and neck carcinoma patients in a university medical center setting , 2001, Cancer.
[142] S. Syrjänen,et al. Oral Manifestations of HPV Infections , 1990 .
[143] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.